KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Other Operating Expenses: 2011-2024

Historic Other Operating Expenses for Novavax (NVAX) over the last 6 years, with Dec 2024 value amounting to $51.9 million.

  • Novavax's Other Operating Expenses rose 95.54% to $118.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $184.6 million, marking a year-over-year decrease of 42.49%. This contributed to the annual value of $51.9 million for FY2024, which is 84.89% down from last year.
  • According to the latest figures from FY2024, Novavax's Other Operating Expenses is $51.9 million, which was down 84.89% from $343.8 million recorded in FY2023.
  • In the past 5 years, Novavax's Other Operating Expenses ranged from a high of $902.6 million in FY2022 and a low of $51.9 million during FY2024.
  • Moreover, its 3-year median value for Other Operating Expenses was $343.8 million (2023), whereas its average is $432.8 million.
  • Data for Novavax's Other Operating Expenses shows a maximum YoY crashed of 84.89% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Novavax's Other Operating Expenses stood at $902.6 million in 2022, then crashed by 61.92% to $343.8 million in 2023, then crashed by 84.89% to $51.9 million in 2024.